Latest News
Read the latest corporate announcements, scientific developments and company news from Glycotest.
Glycotest Licenses Novel Biomarker Intellectual Property from the Medical University of South Carolina to Advance Next-Generation Liver Fibrosis Staging Test
Glycotest, Inc. announced today that it has executed a license agreement with the Zucker Institute for Innovation Commercialization (ZI), the commercialization entity advancing technologies originated from the Medical University of South Carolina (MUSC), for…
Read more →Glycotest secures US$3.22 million to advance liver cancer diagnostic platform
Glycotest has successfully completed the first closing of a US$3.22 million fundraising to accelerate the development and commercialization of its next-generation blood test for liver cancer.The financing includes approximately US$1.05 million in new cash…
Read more →Glycotest’s HCC Panel test for early-stage liver cancer receives additional patent protection in Japan, Singapore, Australia, the Philippines, Hong Kong and China.
Glycotest’s HCC Panel test for early-stage liver cancer receives additional patent protection in Japan, Singapore, Australia, the Philippines, Hong Kong and China.
Read more →Glycotest CEO Charles Swindell to present at Life Science Pennsylvania’s largest partnering event of the year—Life Sciences Future 2025 conference on September 25-26.
Glycotest CEO Charles Swindell to present at Life Science Pennsylvania’s largest partnering event of the year—Life Sciences Future 2025 conference on September 25-26.
Read more →Glycotest shares the HCC Panel liver cancer test opportunity at the Summer 2025 Digital Venture Forum from July 7 to 11
Glycotest shares the HCC Panel liver cancer test opportunity at the Summer 2025 Digital Venture Forum from July 7 to 11
Read more →Charles Swindell, CEO, represents Glycotest in the RESI Europe investor conference, Barcelona, April 1-3
Charles Swindell, CEO, represents Glycotest in the RESI Europe investor conference, Barcelona, April 1-3
Read more →Glycotest to participate in the Spring 2025 Digital Venture Forum investor conference March 17-21, 2025
Glycotest to participate in the Spring 2025 Digital Venture Forum investor conference March 17-21, 2025
Read more →EMV CAPITAL-BACKED GLYCOTEST™ PARTNERS WITH UNIVERSITY OF GEORGIA TO ACCELERATE NOVEL LIVER CANCER DIAGNOSTIC ASSAYS
Merion, PA – 23 September 2024 – Glycotest, Inc. announces that it has entered into an agreement with the University of Georgia Complex Carbohydrate Research Center (CCRC) in Athens, GA to develop novel glycomic…
Read more →Glycotest secures $1 million investment
Glycotest secures $1 million investment
Read more →